- Home
- NUVB vs VTS Comparison
NUVB vs VTS Comparison
Compare NUVB & VTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- VTS
- Stock Information
- Founded
- NUVB 2018
- VTS 2014
- Country
- NUVB United States
- VTS United States
- Employees
- NUVB N/A
- VTS N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- VTS Oil & Gas Production
- Sector
- NUVB Health Care
- VTS Energy
- Exchange
- NUVB Nasdaq
- VTS Nasdaq
- Market Cap
- NUVB 1.1B
- VTS 895.8M
- IPO Year
- NUVB N/A
- VTS N/A
- Fundamental
- Price
- NUVB $5.04
- VTS $22.13
- Analyst Decision
- NUVB Strong Buy
- VTS Strong Buy
- Analyst Count
- NUVB 7
- VTS 4
- Target Price
- NUVB $8.43
- VTS $28.25
- AVG Volume (30 Days)
- NUVB 8.2M
- VTS 303.5K
- Earning Date
- NUVB 11-03-2025
- VTS 11-03-2025
- Dividend Yield
- NUVB N/A
- VTS 10.17%
- EPS Growth
- NUVB N/A
- VTS 27.28
- EPS
- NUVB N/A
- VTS 1.12
- Revenue
- NUVB $14,355,000.00
- VTS $239,904,000.00
- Revenue This Year
- NUVB $291.13
- VTS $28.41
- Revenue Next Year
- NUVB $332.00
- VTS N/A
- P/E Ratio
- NUVB N/A
- VTS $19.83
- Revenue Growth
- NUVB 900.35
- VTS 4.55
- 52 Week Low
- NUVB $1.54
- VTS $18.90
- 52 Week High
- NUVB $5.12
- VTS $28.41
- Technical
- Relative Strength Index (RSI)
- NUVB 76.90
- VTS 40.10
- Support Level
- NUVB $3.36
- VTS $21.86
- Resistance Level
- NUVB $3.84
- VTS $22.19
- Average True Range (ATR)
- NUVB 0.29
- VTS 0.52
- MACD
- NUVB 0.11
- VTS 0.02
- Stochastic Oscillator
- NUVB 95.45
- VTS 36.74
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.